Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.
Remember the recent CDXC insider buying from Hong Kong. They know the future profit potential. The revenue potential from future China sales is staggering.
With the small CDXC float, share price will easily be over $5 and it may happen much sooner than many expect. $7-$8 or higher share price in next 6-9 months. Need to get to $5 first which I expect within next 6 months..
Excerpt:
"Pending--
CBEC launch into China (Sino deal).
New Premium SKU to support Sino (Sino PR).
NextGen Tru Niagen (Nagel convo/ Oppenheimer Conference).
Monetize Patented Next Generation precursors (Key Opinion Leader Webinar)."
Pending--
CBEC launch into China (Sino deal).
New Premium SKU to support Sino (Sino PR).
NextGen Tru Niagen (Nagel convo/ Oppenheimer Conference).
Monetize Patented Next Generation precursors (Key Opinion Leader Webinar).
All TBD.
Lots of stocks have been decimated and some of them are starting to recover. It looks like the bottom is in on many different companies. I think under $2 at this stage of the game is a no-brainer, so I've been back to a little buying. I don't think this will shoot up overnight, but I think as we get deeper into the year and into early 2023 we'll return to our historic levels in the $4 region. That's more than a double from here. I'm interested. Let's see if the call next week can finally get this back over $2 and onward from there.
The Effect of NAD Supplementation on Brain Vascular Health in Aging
ChromaDex to Report Second Quarter 2022 Financial Results on | CDXC Stock News
LOS ANGELES ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed. August 10, 2022 at 4:30 p.m. ET to discuss its financial results for the second quarter, which ended June 30, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.
https://www.stocktitan.net/news/CDXC/chroma-dex-to-report-second-quarter-2022-financial-results-on-xnisu1ybd77q.html
Still, would be nice to see NR go mainstream, would probably raise geezer IQ by 5%.
So, wen NR in Boost?
The infomation in your notification and
amendment was inadequate to demonstrate that your ingredient, "Nicotinamide Riboside
Hydrogen Malate," is completely dissociated into its constituent ions, Nicotinamide Riboside (NR)
ion and L-M alate, upon consumption un der the acidic conditions of the gastrointe stinal (GI) tract.
1
I have not tested positive for Covid. I've been tested 3 times all negative.
I am wondering what others using Tru have experienced with Covid?
To say that Tru can prevent viral illness is specious at best; the viral particles will not be blocked from entering mucosal cells, or lung microcappilary cells.
But symptoms could be mild AND viral titer could be low, possibly too low to detect with a swab (although other tests are more accurate and detect smaller titers).
I know they've done research on Tru and immune response(s) but am wondering about first hand experience regarding those taking Tru for an extended period and covid positive percent?
Specifically who is accountable for making the deals with Nestle, Roman, H&H, and Watson’s work?
Rob, how do you still have a job?
Or some form of
He was already taking 300mg/day Niagen but upped to 600.
I just spoke with him and he sounds terrific. Clear voice and happy. He basically seems totally better in less than 2 weeks.
I know it’s a sample of just 1. I can’t ever say for sure. But this seems remarkable to me because this person in the past has gotten really whooped by common colds. His sinuses almost always develop secondary infections and in general when he gets sick it’s an ordeal that drags for weeks.